J&J to spin off orthopedics business, sees 2026 sales growth of over 5% – Reuters
- J&J to spin off orthopedics business, sees 2026 sales growth of over 5% Reuters
- Johnson & Johnson Earnings Beat Estimates. Why JNJ Stock Is Dropping. Barron’s
- Johnson and Johnson Reveals Plan to Separate Orthopaedics Business Pharmaceutical Executive
- Johnson & Johnson reports results for the quarter ended September 30 – Earnings Summary TradingView
- Johnson & Johnson (JNJ) Q3 2025 Earnings Call Highlights: Strong Growth in Innovative … Yahoo